Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival-Reference-Cited by-同舟云学术

Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

Published:2020-09-24 Issue:11 Volume:111 Page:4218-4231
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci.

Author:

Qin Shu‐Kui¹,Li Qing²,Ming Xu Jian³,Liang Jun⁴,Cheng Ying⁵,Fan Ying²,Jiang Jun²,Ye Hao⁶,Tao Huimin⁷,Li Lian⁷,Zheng Limin⁷,Wei Zhaohui⁸,Li Shu⁹,Meng Kun⁹,Ye Bin⁹^ORCID,Sun Yan²

Affiliation:

1. Clinical Oncology Department Nanjing Jinling Hospital Nanjing China

2. National Cancer Center/National Clinical Research Center Cancer Hospital Chinese Academy of Medical Science and Peking Union Medical College Beijing China

3. The 5th Medical Centre Chinese PLA General Hospital Beijing China

4. Clinical Oncology Department The Affiliated Hospital of Qingdao University Qingdao China

5. Clinical Oncology Department Jilin Cancer Hospital Changchun China

6. Research & Development Department SinoTech Genomics Shanghai China

7. School of Life Science Sun Yat‐Sen University Guangzhou China

8. Biostatistical Department Tigermed Consulting Co., Ltd. Shanghai China

9. Research & Clinical Development Shenogen Pharma Group Beijing China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley